1. Home
  2. MOBX vs RGNT Comparison

MOBX vs RGNT Comparison

Compare MOBX & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mobix Labs Inc.

MOBX

Mobix Labs Inc.

BUY

Current Price

$1.03

Market Cap

17.6M

Sector

N/A

ML Signal

BUY

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$3.36

Market Cap

20.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MOBX
RGNT
Founded
2020
2004
Country
United States
Israel
Employees
46
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.6M
20.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MOBX
RGNT
Price
$1.03
$3.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
83.0M
7.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.13
$3.10
52 Week High
$1.44
$8.35

Technical Indicators

Market Signals
Indicator
MOBX
RGNT
Relative Strength Index (RSI) 72.79 29.72
Support Level $0.78 N/A
Resistance Level $1.44 $4.40
Average True Range (ATR) 0.16 0.30
MACD 0.10 0.01
Stochastic Oscillator 72.49 16.94

Price Performance

Historical Comparison
MOBX
RGNT

About MOBX Mobix Labs Inc.

Mobix Labs Inc designs, develops and sells components and systems for wireless and wired connectivity, radio frequency (RF), switching and electromagnetic interference (EMI) filtering technologies. Its wireless systems solutions include products for RF and millimeter wave (mmWave) communications, mmWave imaging, software defined radio and custom RF integrated circuits (ICs) targeting the defense, aerospace, commercial and industrial sectors. The majority of the company's revenue is derived from product sales to equipment manufacturers. Geographically, it generates the maximum revenue from the United States.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate (a polymer involved in tissue engineering) and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: